BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15112410)

  • 1. [Peculiarities of diagnostics and therapy of atypical pulmonary diseases in Russian hospital in Kosovo].
    Kazakov SP; Papenko IuV; Horkay B
    Voen Med Zh; 2004 Mar; 325(3):38-9. PubMed ID: 15112410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].
    Kubo T; Takigawa N; Tanimoto Y; Ichihara E; Tabata M; Miyahara N; Kanehiro A; Kiura K; Tanimoto M
    Nihon Kokyuki Gakkai Zasshi; 2007 Oct; 45(10):808-11. PubMed ID: 18018632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical bacterial pathogens in community-acquired pneumonia in children: a hospital-based study.
    Agarwal J; Awasthi S; Rajput A; Tiwari M; Jain A
    Trop Doct; 2009 Apr; 39(2):109-11. PubMed ID: 19299299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and treatment of Chlamydia and Mycoplasma infections in patients with bronchoobstructive diseases].
    Kasimtseva SA; Stepanian IE; Lovacheva OV; Shmelev EI
    Probl Tuberk Bolezn Legk; 2006; (2):28-31. PubMed ID: 16610307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycoplasma pneumoniae and Chlamydophila pneumoniae coinfection in severe pneumoniae among a hospitalized child with respiratory distress: what are the best diagnostic tools for an optimal care?].
    Petitjean-Lecherbonnier J; Dina J; Gouarin S; Kozisek S; Poveda JD; Vabret A
    Pathol Biol (Paris); 2010 Dec; 58(6):434-6. PubMed ID: 19375247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of serologic markers against bacterial atypical pneumonia agents in pneumonia patients].
    Pinar A; Ercis S; Ulukavak T; Dursun B; Hasçelik G
    Mikrobiyol Bul; 2004; 38(1-2):27-32. PubMed ID: 15293899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan.
    Bamba M; Jozaki K; Sugaya N; Tamai S; Ishihara J; Kori T; Shiro H; Takeuchi Y; Cho H; Nakao A; Okano Y; Kimura K; Komiyama O; Nonoyama M; Kobayashi I; Kato T; Sunakawa K
    J Infect Chemother; 2006 Feb; 12(1):36-41. PubMed ID: 16506088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical pneumonia.
    Basarab M; Macrae MB; Curtis CM
    Curr Opin Pulm Med; 2014 May; 20(3):247-51. PubMed ID: 24626238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
    Lochindarat S; Suwanjutha S; Prapphal N; Chantarojanasiri T; Bunnag T; Deerojanawong J; Kunakorn M; Srisan P
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):814-9. PubMed ID: 17609060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae and Mycoplasma pneumoniae.
    Blasi F; Tarsia P; Aliberti S; Cosentini R; Allegra L
    Semin Respir Crit Care Med; 2005 Dec; 26(6):617-24. PubMed ID: 16388430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical pneumonia in children.
    Salaria M; Singh M
    Indian Pediatr; 2002 Mar; 39(3):259-66. PubMed ID: 11910135
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood.
    Schmidt SM; Müller CE; Gürtler L; Bruns R; Ballke EH; Wiersbitzky H; Ehlers M; Rose HJ; Wiersbitzky SK
    Klin Padiatr; 2005; 217(1):9-14. PubMed ID: 15640964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.
    Principi N; Esposito S
    Lancet Infect Dis; 2001 Dec; 1(5):334-44. PubMed ID: 11871806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical pneumonia].
    Szilasi M
    Orv Hetil; 2005 Aug; 146(34):1759-66. PubMed ID: 16184877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?
    Johnston SL; Martin RJ
    Am J Respir Crit Care Med; 2005 Nov; 172(9):1078-89. PubMed ID: 15961690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contemporary risks of infections by Mycoplasma pneumoniae and Chlamydophila pneumoniae].
    Grabowska-Krawiec P
    Pol Merkur Lekarski; 2012 Nov; 33(197):270-3. PubMed ID: 23394038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan.
    Izumikawa K; Watanabe A; Miyashita N; Ishida T; Hosono H; Kushimoto S; Kohno S
    J Infect Chemother; 2014 Sep; 20(9):541-8. PubMed ID: 24934886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of atypical pathogens in community-acquired pneumonia.
    Gupta SK; Sarosi GA
    Med Clin North Am; 2001 Nov; 85(6):1349-65, vii. PubMed ID: 11680106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.